Browse > Article
http://dx.doi.org/10.3348/kjr.2016.17.4.533

Diffusion-Weighted MRI of Malignant versus Benign Portal Vein Thrombosis  

Ahn, Jhii-Hyun (Department of Radiology, Yonsei University College of Medicine, Gangnam Severance Hospital)
Yu, Jeong-Sik (Department of Radiology, Yonsei University College of Medicine, Gangnam Severance Hospital)
Cho, Eun-Suk (Department of Radiology, Yonsei University College of Medicine, Gangnam Severance Hospital)
Chung, Jae-Joon (Department of Radiology, Yonsei University College of Medicine, Gangnam Severance Hospital)
Kim, Joo Hee (Department of Radiology, Yonsei University College of Medicine, Gangnam Severance Hospital)
Kim, Ki Whang (Department of Radiology, Yonsei University College of Medicine, Gangnam Severance Hospital)
Publication Information
Korean Journal of Radiology / v.17, no.4, 2016 , pp. 533-540 More about this Journal
Abstract
Objective: To validate the diffusion-weighted MRI (DWI) for differentiation of benign from malignant portal vein thrombosis. Materials and Methods: The Institutional Review Board approved this retrospective study and waived informed consent. A total of 59 consecutive patients (52 men and 7 women, aged 40-85 years) with grossly defined portal vein thrombus (PVT) on hepatic MRI were retrospectively analyzed. Among them, liver cirrhosis was found in 45 patients, and hepatocellular carcinoma in 47 patients. DWI was performed using b values of 50 and $800sec/mm^2$ at 1.5-T unit. A thrombus was considered malignant if it enhanced on dynamic CT or MRI; otherwise, it was considered bland. There were 18 bland thrombi and 49 malignant thrombi in 59 patients, including 8 patients with simultaneous benign and malignant PVT. Mean apparent diffusion coefficients (ADCs) of benign and malignant PVTs were compared by using Mann-Whitney U test. Diagnostic accuracy was evaluated using receiver operating characteristic (ROC) curve analysis. Results: The mean ADC ${\pm}$ standard deviation of bland and malignant PVT were $1.00{\pm}0.39{\times}10^{-3}mm^2/sec$ and $0.92{\pm}0.25{\times}10^{-3}mm^2/sec$, respectively; without significant difference (p = 0.799). The area under ROC curve for ADC was 0.520. An ADC value of $>1.35{\times}10^{-3}mm^2/sec$ predicted bland PVT with a specificity of 94.6% (95% confidence interval [CI]: 84.9-98.9%) and a sensitivity of 22.2% (95% CI: 6.4-47.6%), respectively. Conclusion: Due to the wide range and considerable overlap of the ADCs, DWI cannot differentiate the benign from malignant thrombi efficiently.
Keywords
Portal vein thrombosis; MRI; Diffusion weighted MRI; Apparent diffusion coefficient; Diagnosis; Hepatoma; Hepatocellular carcinoma;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Okuda K, Ohnishi K, Kimura K, Matsutani S, Sumida M, Goto N, et al. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology 1985;89:279-286   DOI
2 Ogren M, Bergqvist D, Bjorck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol 2006;12:2115-2119   DOI
3 Cohen J, Edelman RR, Chopra S. Portal vein thrombosis: a review. Am J Med 1992;92:173-182   DOI
4 Witte CL, Brewer ML, Witte MH, Pond GB. Protean manifestations of pylethrombosis. A review of thirty-four patients. Ann Surg 1985;202:191-202   DOI
5 Akin O, Dixit D, Schwartz L. Bland and tumor thrombi in abdominal malignancies: magnetic resonance imaging assessment in a large oncologic patient population. Abdom Imaging 2011;36:62-68   DOI
6 Sotiropoulos GC, Radtke A, Schmitz KJ, Molmenti EP, Schroeder T, Saner FH, et al. Liver transplantation in the setting of hepatocellular carcinoma and portal vein thrombosis: a challenging dilemma? Dig Dis Sci 2008;53:1994-1999   DOI
7 Takizawa D, Kakizaki S, Sohara N, Sato K, Takagi H, Arai H, et al. Hepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysis. Dig Dis Sci 2007;52:3290-3295   DOI
8 Pirisi M, Avellini C, Fabris C, Scott C, Bardus P, Soardo G, et al. Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study. J Cancer Res Clin Oncol 1998;124:397-400   DOI
9 Sakata J, Shirai Y, Wakai T, Kaneko K, Nagahashi M, Hatakeyama K. Preoperative predictors of vascular invasion in hepatocellular carcinoma. Eur J Surg Oncol 2008;34:900-905   DOI
10 Mathieu D, Grenier P, Larde D, Vasile N. Portal vein involvement in hepatocellular carcinoma: dynamic CT features. Radiology 1984;152:127-132   DOI
11 Tublin ME, Dodd GD 3rd, Baron RL. Benign and malignant portal vein thrombosis: differentiation by CT characteristics. AJR Am J Roentgenol 1997;168:719-723   DOI
12 Bruegel M, Holzapfel K, Gaa J, Woertler K, Waldt S, Kiefer B, et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 2008;18:477-485   DOI
13 Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology 2010;254:47-66   DOI
14 Sandrasegaran K, Akisik FM, Lin C, Tahir B, Rajan J, Aisen AM. The value of diffusion-weighted imaging in characterizing focal liver masses. Acad Radiol 2009;16:1208-1214   DOI
15 Parikh T, Drew SJ, Lee VS, Wong S, Hecht EM, Babb JS, et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology 2008;246:812-822   DOI
16 Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-430   DOI
17 Sandrasegaran K, Tahir B, Nutakki K, Akisik FM, Bodanapally U, Tann M, et al. Usefulness of conventional MRI sequences and diffusion-weighted imaging in differentiating malignant from benign portal vein thrombus in cirrhotic patients. AJR Am J Roentgenol 2013;201:1211-1219   DOI
18 Earls JP, Rofsky NM, DeCorato DR, Krinsky GA, Weinreb JC. Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector. Radiology 1997;202:268-273   DOI
19 Aslam Sohaib SA, Teh J, Nargund VH, Lumley JS, Hendry WF, Reznek RH. Assessment of tumor invasion of the vena caval wall in renal cell carcinoma cases by magnetic resonance imaging. J Urol 2002;167:1271-1275   DOI
20 Kaufman LB, Yeh BM, Breiman RS, Joe BN, Qayyum A, Coakley FV. Inferior vena cava filling defects on CT and MRI. AJR Am J Roentgenol 2005;185:717-726   DOI
21 Ergen FB, Hussain HK, Caoili EM, Korobkin M, Carlos RC, Weadock WJ, et al. MRI for preoperative staging of renal cell carcinoma using the 1997 TNM classification: comparison with surgical and pathologic staging. AJR Am J Roentgenol 2004;182:217-225   DOI
22 Catalano OA, Choy G, Zhu A, Hahn PF, Sahani DV. Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging. Radiology 2010;254:154-162   DOI
23 Battal B, Kocaoglu M, Akgun V, Karademir I, Deveci S, Guvenc I, et al. Diffusion-weighted imaging in the characterization of focal liver lesions: efficacy of visual assessment. J Comput Assist Tomogr 2011;35:326-331   DOI
24 Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver. J Comput Assist Tomogr 2010;34:506-512   DOI
25 Miller FH, Hammond N, Siddiqi AJ, Shroff S, Khatri G, Wang Y, et al. Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions. J Magn Reson Imaging 2010;32:138-147   DOI
26 Kang BK, Na DG, Ryoo JW, Byun HS, Roh HG, Pyeun YS. Diffusion-weighted MR imaging of intracerebral hemorrhage. Korean J Radiol 2001;2:183-191   DOI
27 Connolly GC, Chen R, Hyrien O, Mantry P, Bozorgzadeh A, Abt P, et al. Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma. Thromb Res 2008;122:299-306   DOI
28 Jonas S, Bechstein WO, Steinmüller T, Herrmann M, Radke C, Berg T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001;33:1080-1086   DOI
29 Kim T, Murakami T, Takahashi S, Hori M, Tsuda K, Nakamura H. Diffusion-weighted single-shot echoplanar MR imaging for liver disease. AJR Am J Roentgenol 1999;173:393-398   DOI
30 Gourtsoyianni S, Papanikolaou N, Yarmenitis S, Maris T, Karantanas A, Gourtsoyiannis N. Respiratory gated diffusion-weighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions. Eur Radiol 2008;18:486-492   DOI
31 Silvera S, Oppenheim C, Touze E, Ducreux D, Page P, Domigo V, et al. Spontaneous intracerebral hematoma on diffusion-weighted images: influence of T2-shine-through and T2-blackout effects. AJNR Am J Neuroradiol 2005;26:236-241
32 Kuwahara S, Miyake H, Fukuoka M, Koan Y, Ono Y, Moriki A, et al. Diffusion-weighted magnetic resonance imaging of organized subdural hematoma--case report. Neurol Med Chir (Tokyo) 2004;44:376-379   DOI
33 Bradley WG Jr. MR appearance of hemorrhage in the brain. Radiology 1993;189:15-26   DOI
34 Brooks RA, Di Chiro G, Patronas N. MR imaging of cerebral hematomas at different field strengths: theory and applications. J Comput Assist Tomogr 1989;13:194-206   DOI
35 Does MD, Zhong J, Gore JC. In vivo measurement of ADC change due to intravascular susceptibility variation. Magn Reson Med 1999;41:236-240   DOI
36 Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology 2000;217:331-345   DOI
37 Yu JS, Chung JJ, Kim JH, Kim KW. Limited value of diffusion-weighted MR imaging for differentiating bland from malignant portal venous thrombi. Radiology 2010;256:673-674; author reply 674   DOI